These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 3308081)
41. Phase II evaluation of topotecan for pediatric central nervous system tumors. Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400 [TBL] [Abstract][Full Text] [Related]
42. A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Adamson PC; Balis FM; Belasco JE; Lange B; Berg SL; Blaney SM; Craig C; Poplack DG Cancer Res; 1995 Sep; 55(18):4069-72. PubMed ID: 7664282 [TBL] [Abstract][Full Text] [Related]
43. Phase I trial of caracemide using bolus and infusion schedules. Raber MN; Adams F; Kavanagh J; Legha S; Dimery I; Krakoff I Cancer Treat Rep; 1987 Apr; 71(4):349-52. PubMed ID: 3548956 [TBL] [Abstract][Full Text] [Related]
44. Phase I trial of pentamethylmelamine. Ajani JA; Cabanillas FF; Bodey GP Cancer Treat Rep; 1982 May; 66(5):1227-8. PubMed ID: 6805950 [TBL] [Abstract][Full Text] [Related]
45. Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors. van Eys J; Cangir A; Pack R; Baram T Cancer Treat Rep; 1987 Oct; 71(10):973-4. PubMed ID: 3308081 [TBL] [Abstract][Full Text] [Related]